GLP-1 Drops
US$ 25.82
switching to tirzepatide from dulaglutide improves HbA1c reduction in type 2 diabetes Experiences switching from semaglutide to
Description
This is the one I use (and co-formulated)
Primary Medical Use Semaglutide: Approved for type 2 diabetes and chronic weight management
Longer-term prospective and randomized studies are needed to confirm the durability of weight loss, clarify differential metabolic effects, and evaluate long-term cardiovascular and hepatic outcomes in treatment-nave populations
Pair this with the undisclosed pharmacy partners and the price-leader value proposition starts to look fragile
